The PICI Center at Weill Cornell Medicine performs discovery research to guide the development of new immunotherapeutic approaches that will be delivered by a diverse workforce to all populations. Recognizing the tremendous impact that immunotherapy can have in some cancers but also seeing the unmet clinical need in others, the PICI Center at WCM brings together basic scientists studying cancer cell biology with immunologists and T cell engineers to address these needs. This innovative, multi-disciplinary approach to deploying new therapies across a large, diverse catchment area is achieved through the collaboration of scientists and physician-scientists, community outreach professionals, veterinary oncologists and biomedical engineers. Jedd Wolchok, MD, PhD | Director Taha Merghoub, PhD | Co-Director All Investigators Related Point of View Guest Post: PICI Catalyzes Scientific Innovation Clinical Trial The AMADEUS Trial Clinical Trial The McGRAW Trial Clinical Trial The PRINCE Trial Announcement, Press Release PICI Network Shapes Future of Immunotherapy at AACR 202 Announcement, Press Release PICI and CVC Unite to Accelerate Cancer Vaccines Announcement, Press Release Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth Announcement, Press Release Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer Announcement, Press Release Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
Announcement, Press Release Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth
Announcement, Press Release Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
Announcement, Press Release Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research